<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>654</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15385509</PubmedId>
            <Abstract>Vibrio cholerae is a gram-negative bacterium that has been associated with cholera pandemics since the early 1800s. Whole-cell, killed, and live-attenuated oral cholera vaccines are in use. We and others have focused on the development of a subunit cholera vaccine that features standardized epitopes from various V. cholerae macromolecules that are known to induce protective antibody responses. TcpA protein is assembled into toxin-coregulated pilus (TCP), a type IVb pilus required for V. cholerae colonization, and thus is a strong candidate for a cholera subunit vaccine. Polypeptides (24 to 26 amino acids) in TcpA that can induce protective antibody responses have been reported, but further characterization of their amino acid targets relative to tertiary or quaternary TCP structures has not been done. We report a refinement of the TcpA sequences that can induce protective antibody. One sequence, TcpA 15 (residues 170 to 183), induces antibodies that bind linear TcpA in a Western blot as well as weakly bind soluble TcpA in solution. These antibodies bind assembled pili at high density and provide 80 to 100% protection in the infant mouse protection assay. This is in sharp contrast to other anti-TcpA peptide sera (TcpA 11, TcpA 13, and TcpA 17) that bind very strongly in Western blot and solution assays yet do not provide protection or effectively bind TCP, as evidenced by immunoelectron microscopy. The sequences of TcpA 15 that induce protective antibody were localized on a model of assembled TCP. These sequences are centered on a site that is predicted to be important for TCP structure.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>6050-60</ArticlePages>
            <ArticleTitle>A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Taylor</LastName>
                    <ForeName>Ronald K</ForeName>
                </Author>
                <Author>
                    <LastName>Kirn</LastName>
                    <ForeName>Thomas J</ForeName>
                </Author>
                <Author>
                    <LastName>Meeks</LastName>
                    <ForeName>Michael D</ForeName>
                </Author>
                <Author>
                    <LastName>Wade</LastName>
                    <ForeName>Terri K</ForeName>
                </Author>
                <Author>
                    <LastName>Wade</LastName>
                    <ForeName>William F</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA.</Affiliations>
            <ArticleChemicalList>Antibodies, Bacterial;Cholera Vaccines;Immune Sera;Recombinant Proteins;TcpA protein, Vibrio cholerae;Fimbriae Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Animals, Newborn; Antibodies, Bacterial(immunology); Antibody Specificity; Cholera(immunology; prevention &amp; control); Cholera Vaccines(chemistry; immunology); Enzyme-Linked Immunosorbent Assay; Female; Fimbriae Proteins(chemistry; genetics; immunology); Fimbriae, Bacterial(chemistry; immunology); Immune Sera(immunology); Mice; Models, Molecular; Protein Conformation; Rabbits; Recombinant Proteins(chemistry; genetics; immunology); Solubility; Survival Rate; Vibrio cholerae(immunology; ultrastructure); Virulence</ArticleMeshHeadingsList>
            <Journal>
                <Volume>72</Volume>
                <Issue>10</Issue>
                <Title>Infection and immunity</Title>
                <Issn>0019-9567</Issn>
                <MedlineTa>Infect Immun</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>TcpA-11</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AVALADLGDFENSA</LinearSequence>
                        <StartingPosition>166</StartingPosition>
                        <EndingPosition>179</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P23024.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>127906</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>5261</EpitopeId>
                <ReferenceStartingPosition>141</ReferenceStartingPosition>
                <ReferenceEndingPosition>154</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>6385</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVALADLGDFENSA</LinearSequence>
                                            <StartingPosition>166</StartingPosition>
                                            <EndingPosition>179</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-11</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Rabbits were universally able to make anti-TcpA polypeptide antibodies and the titers increased with time and booster immunizations.  Sera from the preimmune bleed showed low background levels. Antiserum from peptide-immunized rabbits was combined with a known dose of virulent V. cholerae and introduced via gavage into the gut of 4- to 5-day-old infant CD-1 mice, but only short-term protection was conferred.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA-11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AVALADLGDFENSA</LinearSequence>
                                        <StartingPosition>166</StartingPosition>
                                        <EndingPosition>179</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P02769.4</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>6391</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVALADLGDFENSA</LinearSequence>
                                            <StartingPosition>166</StartingPosition>
                                            <EndingPosition>179</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-11</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>161</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunoelectron microscopy was used to determine the ability of anti-TcpA peptide sera to bind assembled TcpA.  The response was moderate.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Assembled Toxin-Coregulated Pilus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>6388</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AVALADLGDFENSA</LinearSequence>
                                            <StartingPosition>166</StartingPosition>
                                            <EndingPosition>179</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-11</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In additional Western Blot assays, it was shown that anti-TcpA polypeptide sera could react with folded, soluble TcpA subunits, which were genetically substituted and grown in E. coli to enhance formation of the TcpA disulfide bond.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TcpA-12</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GDFENSAAAAETG</LinearSequence>
                        <StartingPosition>173</StartingPosition>
                        <EndingPosition>185</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P23024.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>127906</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>18974</EpitopeId>
                <ReferenceStartingPosition>148</ReferenceStartingPosition>
                <ReferenceEndingPosition>160</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>6392</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GDFENSAAAAETG</LinearSequence>
                                            <StartingPosition>173</StartingPosition>
                                            <EndingPosition>185</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-12</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Rabbits were universally able to make anti-TcpA polypeptide antibodies and the titers increased with time and booster immunizations.  Sera from the preimmune bleed showed low background levels. Antiserum from peptide-immunized rabbits was combined with a known dose of virulent V. cholerae and introduced via gavage into the gut of 4- to 5-day-old infant CD-1 mice, but no protection was conferred.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA-12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GDFENSAAAAETG</LinearSequence>
                                        <StartingPosition>173</StartingPosition>
                                        <EndingPosition>185</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P02769.4</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>6395</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GDFENSAAAAETG</LinearSequence>
                                            <StartingPosition>173</StartingPosition>
                                            <EndingPosition>185</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-12</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>161</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Immunoelectron microscopy was used to determine the ability of anti-TcpA peptide sera to bind assembled TcpA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Assembled Toxin-Coregulated Pilus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>6393</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GDFENSAAAAETG</LinearSequence>
                                            <StartingPosition>173</StartingPosition>
                                            <EndingPosition>185</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-12</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>In additional Western Blot assays, it was shown that anti-TcpA polypeptide sera did not react strongly with folded, soluble TcpA subunits, which were genetically substituted and grown in E. coli to enhance formation of the TcpA disulfide bond.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TcpA-13</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AAAETGVGVIKSIAP</LinearSequence>
                        <StartingPosition>180</StartingPosition>
                        <EndingPosition>194</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P23024.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>127906</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>32</EpitopeId>
                <ReferenceStartingPosition>155</ReferenceStartingPosition>
                <ReferenceEndingPosition>169</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>6399</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AAAETGVGVIKSIAP</LinearSequence>
                                            <StartingPosition>180</StartingPosition>
                                            <EndingPosition>194</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-13</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>161</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunoelectron microscopy was used to determine the ability of anti-TcpA peptide sera to bind assembled TcpA. The response was moderate.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Assembled Toxin-Coregulated Pilus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>6396</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AAAETGVGVIKSIAP</LinearSequence>
                                            <StartingPosition>180</StartingPosition>
                                            <EndingPosition>194</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-13</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Rabbits were universally able to make anti-TcpA polypeptide antibodies and the titers increased with time and booster immunizations.  Sera from the preimmune bleed showed low background levels. Antiserum from peptide-immunized rabbits was combined with a known dose of virulent V. cholerae and introduced via gavage into the gut of 4- to 5-day-old infant CD-1 mice, but no protection was conferred.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA-13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AAAETGVGVIKSIAP</LinearSequence>
                                        <StartingPosition>180</StartingPosition>
                                        <EndingPosition>194</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P02769.4</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>6397</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>AAAETGVGVIKSIAP</LinearSequence>
                                            <StartingPosition>180</StartingPosition>
                                            <EndingPosition>194</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-13</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The response was relatively moderate.  In additional Western Blot assays, it was shown that anti-TcpA polypeptide sera could react with folded, soluble TcpA subunits, which were genetically substituted and grown in E. coli to enhance formation of the TcpA disulfide bond.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TcpA-14</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VGVIKSIAPASKNL</LinearSequence>
                        <StartingPosition>186</StartingPosition>
                        <EndingPosition>199</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P23024.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>127906</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>68813</EpitopeId>
                <ReferenceStartingPosition>161</ReferenceStartingPosition>
                <ReferenceEndingPosition>174</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>6400</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VGVIKSIAPASKNL</LinearSequence>
                                            <StartingPosition>186</StartingPosition>
                                            <EndingPosition>199</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-14</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Rabbits were universally able to make anti-TcpA polypeptide antibodies and the titers increased with time and booster immunizations.  Sera from the preimmune bleed showed low background levels. Antiserum from peptide-immunized rabbits was combined with a known dose of virulent V. cholerae and introduced via gavage into the gut of 4- to 5-day-old infant CD-1 mice, but no protection was conferred.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA-14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VGVIKSIAPASKNL</LinearSequence>
                                        <StartingPosition>186</StartingPosition>
                                        <EndingPosition>199</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P02769.4</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>6401</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VGVIKSIAPASKNL</LinearSequence>
                                            <StartingPosition>186</StartingPosition>
                                            <EndingPosition>199</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-14</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In additional Western Blot assays, it was shown that anti-TcpA polypeptide sera did not react with folded, soluble TcpA subunits, which were genetically substituted and grown in E. coli to enhance formation of the TcpA disulfide bond.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>6403</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VGVIKSIAPASKNL</LinearSequence>
                                            <StartingPosition>186</StartingPosition>
                                            <EndingPosition>199</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-14</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>161</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunoelectron microscopy was used to determine the ability of anti-TcpA peptide sera to bind assembled TcpA. The response was poor.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Assembled Toxin-Coregulated Pilus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TcpA-15</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ASKNLDLTNITHVE</LinearSequence>
                        <StartingPosition>195</StartingPosition>
                        <EndingPosition>208</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P23024.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>127906</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>4507</EpitopeId>
                <ReferenceStartingPosition>170</ReferenceStartingPosition>
                <ReferenceEndingPosition>183</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>6404</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ASKNLDLTNITHVE</LinearSequence>
                                            <StartingPosition>195</StartingPosition>
                                            <EndingPosition>208</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-15</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Rabbits were universally able to make anti-TcpA polypeptide antibodies and the titers increased with time andbooster immunizations.  Sera from the preimmune bleed showed low background levels.  Antiserum from peptide-immunized rabbits was combined with a known dose of virulent V. cholerae and introduced via gavage into the gut of 4- to 5-day-old infant CD-1 mice, and  protection was conferred with an 80% survival.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA-15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ASKNLDLTNITHVE</LinearSequence>
                                        <StartingPosition>195</StartingPosition>
                                        <EndingPosition>208</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P02769.4</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>6405</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ASKNLDLTNITHVE</LinearSequence>
                                            <StartingPosition>195</StartingPosition>
                                            <EndingPosition>208</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-15</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The response was relatively moderate.  In additional Western Blot assays, it was shown that anti-TcpA polypeptide sera did not react with folded, soluble TcpA subunits, which were genetically substituted and grown in E. coli to enhance formation of the TcpA disulfide bond.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>6407</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ASKNLDLTNITHVE</LinearSequence>
                                            <StartingPosition>195</StartingPosition>
                                            <EndingPosition>208</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-15</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>161</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunoelectron microscopy was used to determine the ability of anti-TcpA peptide sera to bind assembled TcpA. The response was strong. An alanine substitution experiment revealed that the aspartate at position 175 was crucial for serum reactivity. This was further shown by the significantly lessened reactivity of serum to bind the assembled TCP in immunoelectron microscopy studies.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Assembled Toxin-Coregulated Pilus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TcpA-16</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DLTNITHVEKLC</LinearSequence>
                        <StartingPosition>200</StartingPosition>
                        <EndingPosition>211</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P23024.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>127906</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>9305</EpitopeId>
                <ReferenceStartingPosition>175</ReferenceStartingPosition>
                <ReferenceEndingPosition>186</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>6408</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DLTNITHVEKLC</LinearSequence>
                                            <StartingPosition>200</StartingPosition>
                                            <EndingPosition>211</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-16</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Rabbits were universally able to make anti-TcpA polypeptide antibodies and the titers increased with time and booster immunizations.  Sera from the preimmune bleed showed low background levels. Antiserum from peptide-immunized rabbits was combined with a known dose of virulent V. cholerae and introduced via gavage into the gut of 4- to 5-day-old infant CD-1 mice, but no protection was conferred.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA-16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DLTNITHVEKLC</LinearSequence>
                                        <StartingPosition>200</StartingPosition>
                                        <EndingPosition>211</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P02769.4</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>6409</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DLTNITHVEKLC</LinearSequence>
                                            <StartingPosition>200</StartingPosition>
                                            <EndingPosition>211</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-16</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>In additional Western Blot assays, it was shown that anti-TcpA polypeptide sera did not react with folded, soluble TcpA subunits, which were genetically substituted and grown in E. coli to enhance formation of the TcpA disulfide bond.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>6411</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DLTNITHVEKLC</LinearSequence>
                                            <StartingPosition>200</StartingPosition>
                                            <EndingPosition>211</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-16</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>161</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Immunoelectron microscopy was used to determine the ability of anti-TcpA peptide sera to bind assembled TcpA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Assembled Toxin-Coregulated Pilus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TcpA-17</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KLCKGTAPFGVAFGNS</LinearSequence>
                        <StartingPosition>209</StartingPosition>
                        <EndingPosition>224</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P23024.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>127906</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>31773</EpitopeId>
                <ReferenceStartingPosition>184</ReferenceStartingPosition>
                <ReferenceEndingPosition>199</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>6412</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KLCKGTAPFGVAFGNS</LinearSequence>
                                            <StartingPosition>209</StartingPosition>
                                            <EndingPosition>224</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-17</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Rabbits were universally able to make anti-TcpA polypeptide antibodies and the titers increased with time and booster immunizations.  Sera from the preimmune bleed showed low background levels.  Antiserum from peptide-immunized rabbits was combined with a known dose of virulent V. cholerae and introduced via gavage into the gut of 4- to 5-day-old infant CD-1 mice, but no protection was conferred.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA-17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KLCKGTAPFGVAFGNS</LinearSequence>
                                        <StartingPosition>209</StartingPosition>
                                        <EndingPosition>224</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P02769.4</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>6413</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KLCKGTAPFGVAFGNS</LinearSequence>
                                            <StartingPosition>209</StartingPosition>
                                            <EndingPosition>224</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-17</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In additional Western Blot assays, it was shown that anti-TcpA polypeptide sera could react with folded, soluble TcpA subunits, which were genetically substituted and grown in E. coli to enhance formation of the TcpA disulfide bond.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>6415</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KLCKGTAPFGVAFGNS</LinearSequence>
                                            <StartingPosition>209</StartingPosition>
                                            <EndingPosition>224</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-17</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>161</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunoelectron microscopy was used to determine the ability of anti-TcpA peptide sera to bind assembled TcpA.  The response was poor.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Assembled Toxin-Coregulated Pilus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>TcpA-18</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KGTAPFGVAFGNS</LinearSequence>
                        <StartingPosition>212</StartingPosition>
                        <EndingPosition>224</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P23024.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>127906</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>31067</EpitopeId>
                <ReferenceStartingPosition>187</ReferenceStartingPosition>
                <ReferenceEndingPosition>199</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>6419</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KGTAPFGVAFGNS</LinearSequence>
                                            <StartingPosition>212</StartingPosition>
                                            <EndingPosition>224</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-18</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>161</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunoelectron microscopy was used to determine the ability of anti-TcpA peptide sera to bind assembled TcpA. The response was poor.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Assembled Toxin-Coregulated Pilus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>6416</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KGTAPFGVAFGNS</LinearSequence>
                                            <StartingPosition>212</StartingPosition>
                                            <EndingPosition>224</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-18</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Rabbits were universally able to make anti-TcpA polypeptide antibodies and the titers increased with time and booster immunizations.  Sera from the preimmune bleed showed low background levels.  Antiserum from peptide-immunized rabbits was combined with a known dose of virulent V. cholerae and introduced via gavage into the gut of 4- to 5-day-old infant CD-1 mice, but no protection was conferred.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA-18</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KGTAPFGVAFGNS</LinearSequence>
                                        <StartingPosition>212</StartingPosition>
                                        <EndingPosition>224</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P02769.4</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>6417</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>6 months old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KGTAPFGVAFGNS</LinearSequence>
                                            <StartingPosition>212</StartingPosition>
                                            <EndingPosition>224</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P23024.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>127906</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>TcpA-18</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>200 micrograms administered for first three injections in popliteal lymph nodes (d 0), subcutaneous and intradermal (d 14), or subcutaneous innoculation and popliteal lymph nodes (d 28). On day 56, 100 micrograms injected subcutaneously</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In additional Western Blot assays, it was shown that anti-TcpA polypeptide sera could react with folded, soluble TcpA subunits, which were genetically substituted and grown in E. coli to enhance formation of the TcpA disulfide bond.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>TcpA</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P23024.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>127906</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

